Navigation Links
Frost & Sullivan Accolade for Swissray's Exceptional Dedication to its Customers
Date:2/25/2013

LONDON, Feb. 25, 2013 /PRNewswire/ --Based on its recent analysis of the digital radiography (DR) market, Frost & Sullivan recognizes Swissray Medical AG (Swissray) with the 2012 Europe Customer Value Enhancement Award.

Swissray has pioneered the development of proprietary, state-of-the-art direct digital radiography (ddR) technology. Its exceptional solutions – ddRVersa, ddRCruze, ddRFormula  and ddRElement - represent a perfect blend of best-in-class quality and performance with affordability.

Customization and flexibility are the hallmarks of Swissray's products, which can be modified to meet the actual needs of healthcare facilities, helping end-users achieve maximum efficiency.

Two important reasons end users seeking to replace their installed base with a DR system are workflow optimization and throughput improvement. Radiation dose optimization is also becoming a crucial competitive aspect in the market. High costs of DR systems and quality of maintenance services are among the other focus points for end-users.

"Swissray's strong market position is based on its high-quality, high-performance solutions that can be customized to meet client needs," noted Frost & Sullivan Healthcare Industry Analyst Dominika Grzywinska . "The company's innovative and user-friendly solutions are considered an industry benchmark. Moreover, flexible product pricing enables the company to address the needs of all types of end-users, ranging from large teaching hospitals to smaller facilities with lower throughput."

All Swissray products are available with the company's proprietary software, eXpert. This not only significantly improves workflow, but also minimizes the risk of mistakes. Here again, the software can be adjusted to specific end-user requirements.

"Swissray's products are designed with a special focus on dose minimization," added Grzywinska. "The systems are equipped with a radiation monitoring functionality, initially developed for one of its Scandinavian customers, and which has since been extended to all end-users."

The company adds customer value through price-competitive solutions. Swissray has a flexible manufacturing process, which enables it to meet specific client requirements at the manufacturing stage, rather than modifying ready products. In this way, Swissray's customers need pay only for the features that they actually require.

A key strategic Swissray goal is not only to sell its products, but also to provide support during the entire lifecycle of the system. This vision has underpinned the company's excellence in offering high-quality after-sales services to its customers in Europe and throughout the world.

Comprehensive training sessions are another dimension of Swissray's value-added offerings to its customers. The eXpert Center is an excellence centre that offers customers 24/7 support on clinical applications of Swissray's systems.

"Customers also benefit from the company's Real-time Monitoring service, a service which offers system assessment in real time," remarked Grzywinska. "Any potential issues can be detected ahead of time and downtime can be minimized. This solution ensures an impressive 99 per cent uptime guarantee for Swissray's customers."

Another customer value enhancement is Swissray's proactive support to new customers in site planning and preparation. This ensures maximum efficiency and end-user convenience, as well as safety, crucial in the design of an X-ray site.

The Frost & Sullivan Award for Customer Value Enhancement is presented each year to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. This award recognizes the company's compelling focus on enhancing the value that its customers receive, beyond simply good customer service, leading to improved customer retention and ultimately customer base expansion.

Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Swissray AG

For more than a decade Swissray has been the pioneer and technology leader in the field of digital radiography serving hundreds of health care providers and patients with innovative and cost-effective DR solutions that emphasize excellence in image quality and lower radiation dose. For more information about Swissray's ddR solutions, visit the Swissray website at www.swissray.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:
Catherine Brassell 
Best Practices, Frost & Sullivan
catheirne.brassell@frost.com 
+44.207.9157867


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
2. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
3. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
4. Increasing Surgical Volumes to Boost Use of Tissue Sealants and Topical Haemostats, Says Frost & Sullivan
5. Frost & Sullivan: Digitisation of Australias healthcare system met with widespread apprehension
6. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
7. Gains from a Growing Patient Pool for Cardiac Rhythm Management Devices Offset by Lower Product Pricing, Observes Frost & Sullivan
8. Frost & Sullivan Determines a Real and Urgent Need for Novel Cancer Diagnostics Tests
9. Best Practices Involving Product Innovation and Creation of Value Vital for Customer Retention, Finds Frost & Sullivan
10. Contract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
11. Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... 11, 2016 The primary goal of this ... patterns on the usage of liquid biopsy. Key information ... - Timeframe of liquid biopsy adoption amidst future ... Evs—by organization type - Sample inflow to conduct liquid ... stool, serum, and so on. - Correlation analysis of ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... and improving the lives of pets, today announced the ... the New Animal Drug Application (NADA) for Zimeta™ (dipyrone ... study (KB0120) of Zimeta for the control of pyrexia ... --> --> The ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises ... businesses. , The increasingly modern world of instantaneous consumption proves very convenient for ... sources such as oil and coal, which pollutes our air, water, and soil. It ...
(Date:2/13/2016)... ... February 13, 2016 , ... In the early or “honeymoon” stage of ... perfection, go out of their way to be romantic, and may exaggerate a strength ... at any online dating profile. , A recent study from Queendom.com , ...
(Date:2/12/2016)... ... 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett ... of these scholarships is to encourage applicants to pursue a degree in their field ... two parishes. , “We have available jobs in St. Landry and Evangeline Parishes ...
(Date:2/12/2016)... VA (PRWEB) , ... February 12, 2016 , ... ... Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... in the life cycle of pharmaceutical products, garnering increased attention from all stakeholders ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a technology ... for the ISE Southeast Awards 2016. Finalists and winners of the ISE® Awards ... Executive Forum and Awards Gala on March 15, 2016 at the Westin Peachtree ...
Breaking Medicine News(10 mins):